Loading...
XLONYTT
Market cap1.21bUSD
Jun 12, Last price  
6.50GBP
Name

Zhejiang Yongtai Technology Co Ltd

Chart & Performance

D1W1MN
XLON:YTT chart
P/E
—
P/S
13.70
EPS
—
Div Yield, %
3.89%
Shrs. gr., 5y
0.33%
Rev. gr., 5y
4.61%
Revenues
4.13b
-34.85%
260,680,541288,541,961393,072,284492,811,079511,034,881725,759,212838,874,861769,622,8071,061,449,3421,542,012,5791,748,536,2672,751,122,3063,295,273,7923,429,842,4323,450,306,5504,468,739,4446,336,219,3454,128,040,820
Net income
-620m
L
43,773,43341,149,06243,283,98657,242,92658,318,89063,709,36064,345,31819,848,26183,342,432144,265,024277,018,947182,236,146441,660,042271,699,33277,693,972280,285,674554,106,172-619,761,432
CFO
-329m
L
25,206,37615,126,03962,683,83268,107,4260099,803,86322,253,631166,637,10966,258,15184,232,45919,570,675719,671,411382,071,954345,147,877576,003,356223,682,226-329,126,584
Earnings
May 16, 2025

Profile

Zhejiang Yongtai Technology Co.,Ltd. engages in the research and development, manufacture, and sale of fluorinate chemicals in China. It offers fluorinated pharmaceutical compounds applied to drugs in fields, including anti-diabetic, anti-virus, cardiovascular, anti-bacterial quinolones, nervous system, etc.; and intermediates used in insecticides and fungicide. The company also provides liquid crystal material, lithium battery material, and other energy materials, as well as contract manufacturing service to pharmaceutical and chemical industry. Zhejiang Yongtai Technology Co.,Ltd. was founded in 1999 and is headquartered in Linhai, China.
URL
http://www.yongtaitech.com
IPO date
Dec 22, 2009
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
4,128,041
-34.85%
6,336,219
41.79%
4,468,739
29.52%
Cost of revenue
4,414,764
4,998,702
3,361,963
Unusual Expense (Income)
NOPBT
(286,723)
1,337,518
1,106,776
NOPBT Margin
21.11%
24.77%
Operating Taxes
(98,157)
138,962
107,153
Tax Rate
10.39%
9.68%
NOPAT
(188,566)
1,198,556
999,624
Net income
(619,761)
-211.85%
554,106
97.69%
280,286
260.76%
Dividends
(240,723)
(212,835)
(146,716)
Dividend yield
2.31%
1.11%
0.33%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,652,444
2,561,791
1,997,793
Long-term debt
1,567,569
1,025,015
939,157
Deferred revenue
145,621
130,900
128,096
Other long-term liabilities
234,859
670,999
119,669
Net debt
2,780,210
2,313,128
1,992,587
Cash flow
Cash from operating activities
(329,127)
223,682
576,003
CAPEX
(671,871)
Cash from investing activities
(505,592)
Cash from financing activities
952,403
411,647
167,012
FCF
(430,359)
128,818
440,352
Balance
Cash
1,146,138
980,294
779,144
Long term investments
293,664
293,384
165,218
Excess cash
1,233,401
956,867
720,926
Stockholders' equity
2,789,339
3,252,389
2,964,661
Invested Capital
6,597,854
7,099,148
6,086,040
ROIC
18.18%
17.08%
ROCE
16.57%
16.18%
EV
Common stock shares outstanding
898,205
876,566
876,566
Price
11.62
-46.77%
21.83
-57.37%
51.21
364.70%
Market cap
10,437,142
-45.46%
19,135,442
-57.37%
44,888,959
364.70%
EV
13,743,268
22,043,743
47,093,818
EBITDA
120,266
1,699,185
1,393,951
EV/EBITDA
114.27
12.97
33.78
Interest
168,036
131,907
128,500
Interest/NOPBT
9.86%
11.61%